Charles Schwab’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $50.5M | Sell |
|
|||||
|
2025
Q2 | $47.7M | Sell |
|
|||||
|
2025
Q1 | $49.5M | Buy |
|
|||||
|
2024
Q4 | $63M | Buy |
|
|||||
|
2024
Q3 | $61.7M | Sell |
|
|||||
|
2024
Q2 | $63M | Buy |
|
|||||
|
2024
Q1 | $77.3M | Buy |
|
|||||
|
2023
Q4 | $69.2M | Buy |
|
|||||
|
2023
Q3 | $73.2M | Buy |
|
|||||
|
2023
Q2 | $76.4M | Buy |
|
|||||
|
2023
Q1 | $96M | Buy |
|
|||||
|
2022
Q4 | $82.4M | Buy |
|
|||||
|
2022
Q3 | $76.9M | Buy |
|
|||||
|
2022
Q2 | $89.4M | Buy |
|
|||||
|
2022
Q1 | $98M | Buy |
|
|||||
|
2021
Q4 | $127M | Buy |
|
|||||
|
2021
Q3 | $122M | Buy |
|
|||||
|
2021
Q2 | $102M | Buy |
|
|||||
|
2021
Q1 | $88.3M | Buy |
|
|||||
|
2020
Q4 | $89.8M | Sell |
|
|||||
|
2020
Q3 | $81.5M | Buy |
|
|||||
|
2020
Q2 | $70.4M | Buy |
|
|||||
|
2020
Q1 | $44.9M | Buy |
|
|||||
|
2019
Q4 | $46.7M | Buy |
|
|||||
|
2019
Q3 | $41.8M | Buy |
|
|||||
|
2019
Q2 | $35.9M | Buy |
|
|||||
|
2019
Q1 | $34.9M | Buy |
|
|||||
|
2018
Q4 | $24.6M | Buy |
|
|||||
|
2018
Q3 | $32.7M | Sell |
|
|||||
|
2018
Q2 | $38.9M | Buy |
|
|||||
|
2018
Q1 | $32.1M | Buy |
|
|||||
|
2017
Q4 | $29.3M | Buy |
|
|||||
|
2017
Q3 | $26.3M | Buy |
|
|||||
|
2017
Q2 | $26.1M | Buy |
|
|||||
|
2017
Q1 | $22.6M | Buy |
|
|||||
|
2016
Q4 | $19M | Buy |
|
|||||
|
2016
Q3 | $15.9M | Buy |
|
|||||
|
2016
Q2 | $12.6M | Buy |
|
|||||
|
2016
Q1 | $11.7M | Buy |
|
|||||
|
2015
Q4 | $11.1M | Sell |
|
|||||
|
2015
Q3 | $10.9M | Buy |
|
|||||
|
2015
Q2 | $11.4M | Sell |
|
|||||
|
2015
Q1 | $18.3M | Sell |
|
|||||
|
2014
Q4 | $18.6M | Sell |
|
|||||
|
2014
Q3 | $18.6M | Buy |
|
|||||
|
2014
Q2 | $18.5M | Buy |
|
|||||
|
2014
Q1 | $19.6M | Buy |
|
|||||
|
2013
Q4 | $17M | Buy |
|
|||||
|
2013
Q3 | $15.8M | Buy |
|
|||||
|
2013
Q2 | $12.6M | Buy |
|